WallStreetZenWallStreetZen

NASDAQ: VRCA
Verrica Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for VRCA

Based on 3 analysts offering 12 month price targets for Verrica Pharmaceuticals Inc.
Min Forecast
$10.00+15.34%
Avg Forecast
$13.33+53.78%
Max Forecast
$16.00+84.54%

Should I buy or sell VRCA stock?

Based on 3 analysts offering ratings for Verrica Pharmaceuticals Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VRCA stock forecasts and price targets.

VRCA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2023-12-15

1 of 1

Forecast return on equity

Is VRCA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.34%

Forecast return on assets

Is VRCA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VRCA revenue forecast

What is VRCA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$25.9M+190.84%
Avg 2 year Forecast
$81.3M+812.44%
Avg 3 year Forecast
$152.8M+1,614.3%
VRCA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VRCA revenue growth forecast

How is VRCA forecast to perform vs Biotechnology companies and vs the US market?
Company
156.33%
Industry
37.64%
Market
9.99%
VRCA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VRCA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VRCA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VRCA$9.15$13.33+45.72%Strong Buy
FBLG$11.80N/AN/A
CTNM$14.96$28.00+87.17%Strong Buy
TRML$15.00$64.67+331.11%Strong Buy
AVXL$4.50$40.00+788.89%Buy

Verrica Pharmaceuticals Stock Forecast FAQ

Is Verrica Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: VRCA) stock is to Strong Buy VRCA stock.

Out of 3 analysts, 1 (33.33%) are recommending VRCA as a Strong Buy, 2 (66.67%) are recommending VRCA as a Buy, 0 (0%) are recommending VRCA as a Hold, 0 (0%) are recommending VRCA as a Sell, and 0 (0%) are recommending VRCA as a Strong Sell.

If you're new to stock investing, here's how to buy Verrica Pharmaceuticals stock.

What is VRCA's revenue growth forecast for 2024-2026?

(NASDAQ: VRCA) Verrica Pharmaceuticals's forecast annual revenue growth rate of 156.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.99%.

Verrica Pharmaceuticals's revenue in 2024 is $8,913,000.On average, 3 Wall Street analysts forecast VRCA's revenue for 2024 to be $1,099,655,034, with the lowest VRCA revenue forecast at $1,039,291,299, and the highest VRCA revenue forecast at $1,193,276,091. On average, 3 Wall Street analysts forecast VRCA's revenue for 2025 to be $3,449,853,230, with the lowest VRCA revenue forecast at $2,725,064,205, and the highest VRCA revenue forecast at $4,029,905,035.

In 2026, VRCA is forecast to generate $6,481,614,418 in revenue, with the lowest revenue forecast at $4,637,784,394 and the highest revenue forecast at $8,271,910,335.

What is VRCA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VRCA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VRCA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year VRCA price target, the average VRCA price target is $13.33, with the highest VRCA stock price forecast at $16.00 and the lowest VRCA stock price forecast at $10.00.

On average, Wall Street analysts predict that Verrica Pharmaceuticals's share price could reach $13.33 by May 16, 2025. The average Verrica Pharmaceuticals stock price prediction forecasts a potential upside of 45.72% from the current VRCA share price of $9.15.

What is VRCA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VRCA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.